Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03032432Phase 4Withdrawn
Phase 4, randomised, single-blind trial in rotator cuff tendinopathy (RCT), sponsored by Loma Linda University. Primary endpoint: Short Form-36 at 12 months. Planned start Jun 2018; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03032432.